Association of acid phosphatase locus 1*;C allele with the risk of cardiovascular events in rheumatoid arthritis patients

Arthritis Research and Therapy

Volumn 13, Issue 4, 2011, Pages

  Teruel, María ^a   Martin, Jose Ezequiel ^a   González Juanatey, Carlos ^b   López Mejias, Raquel ^c   Miranda Filloy, Jose A ^b   Blanco, Ricardo ^c   Balsa, Alejandro ^d   Pascual Salcedo, Dora ^d   Rodriguez Rodriguez, Luis ^e   Fernández Gutierrez, Benjamin ^e   Ortiz, Ana M ^f   González Alvaro, Isidoro ^f   Gómez Vaquero, Carmen ^g   Bottini, Nunzio ^h   Llorca, Javier ⁱ   González Gay, Miguel A ^c   Martin, Javier ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL XERAL CALDE   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^f HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^g HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^h LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

ⁱ UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; ACP1 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN TYROSINE PHOSPHATASE;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; CARDIOVASCULAR DISEASE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR;

ALLELES; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASES; PROTO-ONCOGENE PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 79960554904     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3401     Document Type: Article

References (30)

1. Gregersen PK. Susceptibility genes for rheumatoid arthritis-a rapidly expanding harvest. Bull NYU Hosp Jt Dis 2010, 68:179-182.
2. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005, 35:8-17. 10.1016/j.semarthrit.2005.03.004, 16084219.
3. Full LE, Ruisanchez C, Monaco C. The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther 2009, 11:217. 10.1186/ar2631, 2688172, 19435478.
4. Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Pineiro A, Garcia-Porrua C, Miranda-Filloy JA, Ollier WE, Martin J, Llorca J. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 2007, 57:125-132. 10.1002/art.22482, 17266100.
5. Bottini N, Bottini E, Gloria-Bottini F, Mustelin T. Low-molecular-weight protein tyrosine phosphatase and human disease: in search of biochemical mechanisms. Arch Immunol Ther Exp (Warsz) 2002, 50:95-104.
6. Lazaruk KD, Dissing J, Sensabaugh GF. Exon structure at the human ACP1 locus supports alternative splicing model for f and s isozyme generation. Biochem Biophys Res Commun 1993, 196:440-446. 10.1006/bbrc.1993.2269, 8216326.
7. Dissing J. Immunochemical characterization of human red cell acid phosphatase isozymes. Biochem Genet 1987, 25:901-918. 10.1007/BF00502609, 3130837.
8. Apelt N, da Silva AP, Ferreira J, Alho I, Monteiro C, Marinho C, Teixeira P, Sardinha L, Laires MJ, Mascarenhas MR, Bicho MP. ACP1 genotype, glutathione reductase activity, and riboflavin uptake affect cardiovascular risk in the obese. Metabolism 2009, 58:1415-1423. 10.1016/j.metabol.2009.05.007, 19570551.
9. Souza AC, Azoubel S, Queiroz KC, Peppelenbosch MP, Ferreira CV. From immune response to cancer: a spot on the low molecular weight protein tyrosine phosphatase. Cell Mol Life Sci 2009, 66:1140-1153. 10.1007/s00018-008-8501-8, 19002379.
10. Chiarugi P, Cirri P, Raugei G, Manao G, Taddei L, Ramponi G. Low M® phosphotyrosine protein phosphatase interacts with the PDGF receptor directly via its catalytic site. Biochem Biophys Res Commun 1996, 219:21-25. 10.1006/bbrc.1996.0174, 8619809.
11. Rigacci S, Rovida E, Bagnoli S, Dello Sbarba P, Berti A. Low M® phosphotyrosine protein phosphatase activity on fibroblast growth factor receptor is not associated with enzyme translocation. FEBS Lett 1999, 459:191-194. 10.1016/S0014-5793(99)01234-X, 10518016.
12. Taddei ML, Chiarugi P, Cirri P, Talini D, Camici G, Manao G, Raugei G, Ramponi G. LMW-PTP exerts a differential regulation on PDGF- and insulin-mediated signaling. Biochem Biophys Res Commun 2000, 270:564-569. 10.1006/bbrc.2000.2456, 10753664.
13. Pandey SK, Yu XX, Watts LM, Michael MD, Sloop KW, Rivard AR, Leedom TA, Manchem VP, Samadzadeh L, McKay RA, Monia BP, Bhanot S. Reduction of low molecular weight protein-tyrosine phosphatase expression improves hyperglycemia and insulin sensitivity in obese mice. J Biol Chem 2007, 282:14291-14299. 10.1074/jbc.M609626200, 17353188.
14. Kikawa KD, Vidale DR, Van Etten RL, Kinch MS. Regulation of the EphA2 kinase by the low molecular weight tyrosine phosphatase induces transformation. J Biol Chem 2002, 277:39274-39279. 10.1074/jbc.M207127200, 12167657.
15. Bottini N, Stefanini L, Williams S, Alonso A, Jascur T, Abraham RT, Couture C, Mustelin T. Activation of ZAP-70 through specific dephosphorylation at the inhibitory Tyr-292 by the low molecular weight phosphotyrosine phosphatase (LMPTP). J Biol Chem 2002, 277:24220-24224. 10.1074/jbc.M202885200, 11976341.
16. Bottini E, Gloria-Bottini F, Borgiani P. ACP1 and human adaptability. 1. Association with common diseases: a case-control study. Hum Genet 1995, 96:629-637. 10.1007/BF00210290, 8522318.
17. Banci M, Saccucci P, D'Annibale F, Dofcaci A, Trionfera G, Magrini A, Bottini N, Bottini E, Gloria-Bottini F. ACP1 genetic polymorphism and coronary artery disease: an association study. Cardiology 2009, 113:236-242. 10.1159/000203405, 19246900.
18. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
19. Gonzalez-Juanatey C, Llorca J, Martin J, Gonzalez-Gay MA. Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum 2009, 38:366-371. 10.1016/j.semarthrit.2008.01.012, 18336869.
20. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81:559-575. 10.1086/519795, 1950838, 17701901.
21. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265. 10.1093/bioinformatics/bth457, 15297300.
22. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006, 38:209-213. 10.1038/ng1706, 16415888.
23. Spencer N, Hopkinson DA, Harris H. Quantitative differences and gene dosage in the human red cell acid phosphatase polymorphism. Nature 1964, 201:299-300. 10.1038/201299a0, 14110459.
24. Chaves FJ, Mansego ML, Blesa S, Gonzalez-Albert V, Jimenez J, Tormos MC, Espinosa O, Giner V, Iradi A, Saez G, Redon J. Inadequate cytoplasmic antioxidant enzymes response contributes to the oxidative stress in human hypertension. Am J Hypertens 2007, 20:62-69. 10.1016/j.amjhyper.2006.06.006, 17198913.
25. Serdar Z, Aslan K, Dirican M, Sarandol E, Yesilbursa D, Serdar A. Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. Clin Biochem 2006, 39:794-803. 10.1016/j.clinbiochem.2006.02.004, 16600205.
26. Bottini N, MacMurray J, Peters W, Rostamkhani M, Comings DE. Association of the acid phosphatase (ACP1) gene with triglyceride levels in obese women. Mol Genet Metab 2002, 77:226-229. 10.1016/S1096-7192(02)00120-8, 12409270.
27. Farragher TM, Goodson NJ, Naseem H, Silman AJ, Thomson W, Symmons D, Barton A. Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum 2008, 58:359-69. 10.1002/art.23149, 3001034, 18240242.
28. Gonzalez-Gay MA, Llorca J, Palomino-Morales R, Gomez-Acebo I, Gonzalez-Juanatey C, Martin J. Influence of nitric oxide synthase gene polymorphisms on the risk of cardiovascular events in rheumatoid arthritis. Clin Exp Rheumatol 2009, 27:116-119.
29. Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Rodriguez L, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, Gonzalez-Gay MA. A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis. Arthritis Res Ther 2010, 12:R71. 2888227, 20423475.
30. Rodríguez-Rodríguez L, González-Juanatey C, Palomino-Morales R, Vázquez-Rodríguez TR, Miranda-Filloy JA, Fernández-Gutiérrez B, Llorca J, Martin J, González-Gay MA. TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. Atherosclerosis 2011, 216:125-30. 10.1016/j.atherosclerosis.2010.10.052, 21420089.